Engineering of ES Cell Genomes with Recombinase Systems

Handbook of Stem Cells

Volumn 1, Issue , 2004, Pages 609-622

  Von Melchner, Harald ^a   Stewart, A Francis ^b  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18844453897     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50070-5     Document Type: Chapter

References (85)

1. Ringrose L., Chabanis S., Angrand P.O., Woodroofe C., Stewart A.F. Comparative kinetic analysis of FLP and cre recombinases: Mathematical models for DNA binding and recombination. J. Mol. Biol. 1998, 284:363-384.
2. Van Duyne G.D. A structural view of cre/loxp site-specific recombination. Annu. Rev. Biophys. Biomol. Struct. 2001, 30:87-104.
3. Chen Y., Rice P.A. New insight into site-specific recombination from FLP recombinase-DNA structures. Annu. Rev. Biophys. Biomol. Struct. 2003, 32:135-159.
4. Logie C., Stewart A.F. Ligand-regulated site-specific recombination. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:5940-5944.
5. Lam K.P., Rajewsky K. Rapid elimination of mature autoreactive B-cells demonstrated by Cre-induced change in B-cell antigen receptor specificity in vivo. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13,171-13,175.
6. Testa G., Stewart A.F. Creating a transloxation: engineering interchromosomal translocations in the mouse. EMBO Rep. 2000, 1:120-121.
7. Albert H., Dale E.C., Lee E., Ow D.W. Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J. 1995, 7:649-659.
8. Araki K., Araki M., Yamamura K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 1997, 25:868-872.
9. Zhang Z., Lutz B. Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB-binding protein. Nucleic Acids Res. 2002, 30:e90.
10. Schlake T., Bode J. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 1994, 33:12,746-12,751.
11. Baer A., Bode J. Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr. Opin. Biotechnol. 2001, 12:473-480.
12. Seibler J., Schubeler D., Fiering S., Groudine M., Bode J. DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs. Biochemistry 1998, 37:6229-6234.
13. Lee G., Saito I. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene 1998, 216:55-65.
14. Langer S.J., Ghafoori A.P., Byrd M., Leinwand L. A genetic screen identifies novel noncompatible loxP sites. Nucleic Acids Res. 2002, 30:3067-3077.
15. Kolb A.F. Selection marker-free modification of the murine β-casein gene using a lox2272 [correction of lox2722] site. Anal. Biochem. 2001, 290:260-271.
16. Lauth M., Spreafico F., Dethleffsen K., Meyer M. Stable and efficient cassette exchange under nonselectable conditions by combined use of two site-specific recombinases. Nucleic Acids Res. 2002, 30:e115.
17. Feng Y.Q., Seibler J., Alami R., Eisen A., Westerman K.A., Leboulch P., Fiering S., Bouhassira E.E. Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J. Mol. Biol. 1999, 292:779-785.
18. Schnutgen F., Doerflinger N., Calleja C., Wendling O., Chambon P., Ghyselinck N.B. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 2003, 21:562-565.
19. Smith M.C., Thorpe H.M. Diversity in the serine recombinases. Mol. Microbiol. 2002, 44:299-307.
20. Thorpe H.M., Smith M.C. In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase-invertase family. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5505-5510.
21. Groth A.C., Olivares E.C., Thyagarajan B., Calos M.P. A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5995-6000.
22. Thorpe H.M., Wilson S.E., Smith M.C. Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31. Mol. Microbiol. 2000, 38:232-241.
23. Andreas S., Schwenk F., Kuter-Luks B., Faust N., Kuhn R. Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res. 2002, 30:2299-2306.
24. Belteki G., Gertsenstein M., Ow D.W., Nagy A. Site-specific cassette exchange and germ line transmission with mouse ES cells expressing phiC31 integrase. Nat. Biotechnol. 2003, 21:321-324.
25. Thyagarajan B., Olivares E.C., Hollis R.P., Ginsburg D.S., Calos M.P. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell Biol. 2001, 21:3926-3934.
26. Olivares E.C., Hollis R.P., Chalberg T.W., Meuse L., Kay M.A., Calos M.P. Site-specific genomic integration produces therapeutic factor IX levels in mice. Nat. Biotechnol. 2002, 20:1124-1128.
27. Ortiz-Urda S., Thyagarajan B., Keene D.R., Lin Q., Fang M., Calos M.P., Khavari P.A. Stable nonviral genetic correction of inherited human skin disease. Nat. Med. 2002, 8:1166-1170.
28. Buchholz F., Angrand P.O., Stewart A.F. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 1998, 16:657-662.
29. Rodriguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre/loxP. Nat. Genet. 2000, 25:139-140.
30. Buchholz F., Stewart A.F. Alteration of Cre recombinase site specificity by substrate-linked protein evolution. Nat. Biotechnol. 2001, 19:1047-1052.
31. Santoro S.W., Schultz P.G. Directed evolution of the site specificity of Cre recombinase. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4185-4190.
32. Voziyanov Y., Konieczka J.H., Stewart A.F., Jayaram M. Stepwise manipulation of DNA specificity in Flp recombinase: progressively adapting Flp to individual and combinatorial mutations in its target site. J. Mol. Biol. 2003, 326:65-76.
33. Sclimenti C.R., Thyagarajan B., Calos M.P. Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res. 2001, 29:5044-5051.
34. Schwenk F., Kuhn R., Angrand P.O., Rajewsky K., Stewart A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 1998, 26:1427-1432.
35. Schmidt E.E., Taylor D.S., Prigge J.R., Barnett S., Capecchi M.R. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13,702-13,707.
36. Ringrose L., Chabanis S., Angrand P.O., Woodroofe C., Stewart A.F. Quantitative comparison of DNA looping in vitro and in vivo: chromatin increases effective DNA flexibility at short distances. EMBO J. 1999, 18:6630-6641.
37. Vooijs M., Jonkers J., Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2001, 2:292-297.
38. Fitzgerald D.P., Bender W. Polycomb group repression reduces DNA accessibility. Mol. Cell Biol. 2001, 21:6585-6597.
39. Herault Y., Rassoulzadegan M., Cuzin F., Duboule D. Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat. Genet. 1998, 20:381-384.
40. Ramirez-Solis R., Liu P., Bradley A. Chromosome engineering in mice. Nature 1995, 378:720-724.
41. Choulika A., Guyot V., Nicolas J.F. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site. J. Virol. 1996, 70:1792-1798.
42. Russ A.P., Friedel C., Grez M., von Melchner H. Self-deleting retrovirus vectors for gene therapy. J. Virol. 1996, 70:4927-4932.
43. Pfeifer A., Brandon E.P., Kootstra N., Gage F.H., Verma I.M. Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11,450-11,455.
44. Akagi K., Sandig V., Vooijs M., Van der Valk M., Giovannini M., Strauss M., Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res. 1997, 25:1766-1773.
45. Meuwissen R., Linn S.C., van der Valk M., Mooi W.J., Berns A. Mouse model for lung tumorigenesis through Cre-lox-controlled sporadic activation of the K-Ras oncogene. Oncogene 2001, 20:6551-6558.
46. Jo D., Nashabi A., Doxsee C., Lin Q., Unutmaz D., Chen J., Ruley H.E. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat. Biotechnol. 2001, 19:929-933.
47. Peitz M., Pfannkuche K., Rajewsky K., Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4489-4494.
48. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science 1995, 269:1427-1429.
49. Schonig K., Bujard H. Generating conditional mouse mutants via tetracycline-controlled gene expression. Methods Mol. Biol. 2003, 209:69-104.
50. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2001, 2:743-755.
51. Utomo A.R., Nikitin A.Y., Lee W.H. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 1999, 17:1091-1096.
52. Schonig K., Schwenk F., Rajewsky K., Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 2002, 30:e134.
53. Cronin C.A., Gluba W., Scrable H. The lac operator-repressor system is functional in the mouse. Genes Dev. 2001, 15:1506-1517.
54. Metzger D., Feil R. Engineering the mouse genome by site-specific recombination. Curr. Opin. Biotechnol. 1999, 10:470-476.
55. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
56. Zambrowicz B.P., Sands A.T. Knockouts model the 100 best-selling drugs: will they model the next 100?. Nat. Rev. Drug Discov. 2003, 2:38-51.
57. Kuhn R., Schwenk F. Conditional knockout mice. Methods Mol. Biol. 2003, 209:159-185.
58. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., Kanamaru R., Kanegae Y., Saito I., Nakamura Y., Shiba K., Noda T. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997, 278:120-123.
59. Schaft J., Ashery-Padan R., van der Hoeven F., Gruss P., Stewart A.F. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 2001, 31:6-10.
60. Kaul A., Koster M., Neuhaus H., Braun T. Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5-mutant mice. Cell 2000, 102:17-19.
61. Nagy A., Moens C., Ivanyi E., Pawling J., Gertsenstein M., Hadjantonakis A.K., Pirity M., Rossant J. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 1998, 8:661-664.
62. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 1998, 18:136-141.
63. Seibler J., Zevnik B., Kuter-Luks B., Andreas S., Kern H., Hennek T., Rode A., Heimann C., Faust N., Hauselmann G., Schoor M., Jaenisch R., Rajewsky K., Kuhn R., Schwenk F. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003, 31:e12.
64. Bruning J.C., Michael M.D., Winnay J.N., Hayashi T., Horsch D., Accili D., Goodyear L.J., Kahn C.R. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 1998, 2:559-569.
65. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
66. Stanford W.L., Cohn J.B., Cordes S.P. Gene trap mutagenesis: past, present, and beyond. Nat. Rev. Genet. 2001, 2:756-768.
67. Friedrich G., Soriano P. Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes Dev. 1991, 5:1513-1523.
68. Mitchell K.J., Pinson K.I., Kelly O.G., Brennan J., Zupicich J., Scherz P., Leighton P.A., Goodrich L.V., Lu X., Avery B.J., Tate P., Dill K., Pangilinan E., Wakenight P., Tessier-Lavigne M., Skarnes W.C. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 2001, 28:241-249.
69. Gebauer M., von Melchner H., Beckers T. Genomewide trapping of genes that encode secreted and transmembrane proteins repressed by oncogenic signaling. Genome Res. 2001, 11:1871-1877.
70. Angrand P.O., Woodroofe C.P., Buchholz F., Stewart A.F. Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells. Nucleic Acids Res. 1998, 26:3263-3269.
71. Pasqualetti M., Ren S.Y., Poulet M., LeMeur M., Dierich A., Rijli F.M. A Hoxa2 knockin allele that expresses EGFP upon conditional Cre-mediated recombination. Genesis 2002, 32:109-111.
72. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
73. Mao X., Fujiwara Y., Chapdelaine A., Yang H., Orkin S.H. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 2001, 97:324-326.
74. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter mouse strain. Nat. Genet. 1999, 21:70-71.
75. Thorey I.S., Muth K., Russ A.P., Otte J., Reffelmann A., von Melchner H. Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination. Mol. Cell Biol. 1998, 18:3081-3088.
76. Zheng B., Sage M., Sheppeard E.A., Jurecic V., Bradley A. Engineering mouse chromosomes with Cre/loxP: Range, efficiency, and somatic applications. Mol. Cell Biol. 2000, 20:648-655.
77. Smith A.J., De Sousa M.A., Kwabi-Addo B., Heppell-Parton A., Impey H., Rabbitts P. A site-directed chromosomal translocation induced in embryonic stem cells by Cre/loxP recombination. Nat. Genet. 1995, 9:376-385.
78. Liu P., Jenkins N.A., Copeland N.G. Efficient Cre/loxP-induced mitotic recombination in mouse embryonic stem cells. Nat. Genet. 2002, 30:66-72.
79. Koike H., Horie K., Fukuyama H., Kondoh G., Nagata S., Takeda J. Efficient biallelic mutagenesis with Cre/loxP-mediated interchromosomal recombination. EMBO Rep. 2002, 3:433-437.
80. Yu Y., Bradley A. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2001, 2:780-790.
81. Mortensen R.M., Conner D.A., Chao S., Geisterfer-Lowrance A.A., Seidman J.G. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell Biol. 1992, 12:2391-2395.
82. Lefebvre L., Dionne N., Karaskova J., Squire J.A., Nagy A. Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity. Nat. Genet. 2001, 27:257-258.
83. Su H., Wang X., Bradley A. Nested chromosomal deletions induced with retroviral vectors in mice. Nat. Genet. 2000, 24:92-95.
84. Testa G., Zhang Y., Vintersten K., Benes V., Pijnappel W.W., Chambers I., Smith A.J., Smith A.G., Stewart A.F. Engineering the mouse genome with bacterial artificial chromosomes to create multipurpose alleles. Nat. Biotechnol. 2003, 21:443-447.
85. Collins E.C., Pannell R., Simpson E.M., Forster A., Rabbitts T.H. Interchromosomal recombination of Mll and Af9 genes mediated by cre/loxP in mouse development. EMBO Rep. 2000, 1:127-132.